The Seton Hall students want the university to hire staff, restore the Africana Studies Department, and give them a role in selecting a program director.
at Presidents Hall on the South Orange campus on Wednesday — with some sleeping there overnight — to protest what they said is the university’s lack of support for the Africana Studies program.
Organized by the group Protect African American Studies Movement, the protestors said the Africana Studies program has no tenured professors, and it’s impossible for students to complete majors or minors in it. If you purchase a product or register for an account through one of the links on our site, we may receive compensation.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Seton Hall students stage walkout, demand support for Africana Studies programStudents say only a limited number of people can attend and it's often dropped because the school is not committed to the program.
Read more »
Seton Hall University students protest to save Africana Studies programAccording to the student newspaper, the program lost its only faculty member last fall.
Read more »
A Trailblazer of Trauma Studies Asks What Victims Really WantIn “Truth and Repair,” Judith Herman argues that neither the traditional model of retributive justice, with its emphasis on punishment, nor the burgeoning alternative of restorative justice, with its focus on forgiveness, truly prioritizes survivors.
Read more »
Case Western Reserve Provost Ben Vinson III named new president of Howard UniversityICYMI: Vinson is a historian specializing in studies of the African diaspora, particularly in Latin America. He will soon serve as the president of Howard University, an HBCU in Washington, D.C.
Read more »
Gender differences in peer reviewed grant applications, awards, and amounts: a systematic review and meta-analysis - Research Integrity and Peer ReviewBackground Differential participation and success in grant applications may contribute to women’s lesser representation in the sciences. This study’s objective was to conduct a systematic review and meta-analysis to address the question of gender differences in grant award acceptance rates and reapplication award acceptance rates (potential bias in peer review outcomes) and other grant outcomes. Methods The review was registered on PROSPERO (CRD42021232153) and conducted in accordance with PRISMA 2020 standards. We searched Academic Search Complete, PubMed, and Web of Science for the timeframe 1 January 2005 to 31 December 2020, and forward and backward citations. Studies were included that reported data, by gender, on any of the following: grant applications or reapplications, awards, award amounts, award acceptance rates, or reapplication award acceptance rates. Studies that duplicated data reported in another study were excluded. Gender differences were investigated by meta-analyses and generalized linear mixed models. Doi plots and LFK indices were used to assess reporting bias. Results The searches identified 199 records, of which 13 were eligible. An additional 42 sources from forward and backward searches were eligible, for a total of 55 sources with data on one or more outcomes. The data from these studies ranged from 1975 to 2020: 49 sources were published papers and six were funders’ reports (the latter were identified by forwards and backwards searches). Twenty-nine studies reported person-level data, 25 reported application-level data, and one study reported both: person-level data were used in analyses. Award acceptance rates were 1% higher for men, which was not significantly different from women (95% CI 3% more for men to 1% more for women, k = 36, n = 303,795 awards and 1,277,442 applications, I2 = 84%). Reapplication award acceptance rates were significantly higher for men (9%, 95% CI 18% to 1%, k = 7, n = 7319 applications and 3324 awards, I2 = 63%
Read more »
Watch out, Ozempic? Another diabetes drug leads to impressive weight loss in studiesTirzepatide, which is sold under the brand name Mounjaro, has now shown striking results in two clinical trials.
Read more »